The PTAB, pharmaceutical patents and reverse payments

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

The PTAB, pharmaceutical patents and reverse payments

August 03 2016
PTAB icon 165

The authors of a new white paper believe that almost 75% of pharmaceutical patent settlements at the Patent Trial and Appeal Board meet the criterion for inferring a strong likelihood of reverse payment settlement. The paper also suggests a rule to deter attempts to exploit the Board as a holdup device as well as discussing reverse patent trolls

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

United StatesNewsPatentsNorth AmericaJurisdictions
more from across site and SHARED ros bottom lb

More from across our site

Patents
Netflix.jpg
Baker Botts leads Netflix to victory in fraudulent patent transfer claim
The US decision marks a rare grant of a request under the Uniform Fraudulent Transfer Act in a patent case
Sukanya Sarkar, March 25 2026
Trademarks
Rolls 2k-comp.jpg
IP law firm contempt of court battle heats up
Stobbs has applied to strike out a contempt of court application filed against the firm and two of its lawyers
Max Walters, March 25 2026
Trademarks
Agentic ai workflow artificial intelligence technology automation glowing data stream merges with digital gears futuristic creative concept
From reactive clearance to AI-powered brand intelligence
With trademark volumes surging, trademark teams need to think beyond traditional clearance searches, towards a continuous, intelligence-led workflow, says Meghan Medeiros of Corsearch
Meghan Medeiros, March 25 2026
Patents
Copy of WcW generic.png
‘Invisible benefits’: tech push by Brazilian law firms leaves clients unconvinced
Brazilian in-house counsel say law firms’ technology investments have not translated into tangible benefits, meaning tech use is a minor factor when selecting advisers
Sanjana Mishra, March 25 2026
Trademarks
Fitting in.jpg
Weekly take: Why diversity mandates won’t lead to inclusivity
A lack of comfort among some salaried partners shows why law firms must actively foster inclusion, not merely focus on diversity mandates
Sukanya Sarkar, March 24 2026
Trademarks
IMG_1321.jpeg
ECIJA hires 12-lawyer TM team from Hoyng Rokh Monegier
Arrival of Laura Alonso, alongside a team of 11, will bring ‘significant value’ to ECIJA clients, says CEO
March 24 2026
Patents
A judge's gavel rests on a sound block with a blurred Chinese flag in the background, symbolizing law and justice in China.
Overturning Chinese invalidation decisions: timelines and procedures
In the first of a two-part article, lawyers at Spruson & Ferguson and Marshall Gerstein provide an overview of China’s system for appealing against patent invalidation decisions
Siqi Wang, March 23 2026
Patents
The Statue of Liberty over the Scene of New york cityscape river
‘Always work in tandem’: how IP is driving corporate deals
Lawyers and corporate leaders at INTA’s Business of M&A conference in New York discussed how cross-practice collaboration and early in-house involvement can help deals
Sanjana Mishra, March 23 2026
Patents
li_lily_press_3800x4600.jpg
Preservation and persuasion: inside Morrison Foerster’s ITC victory against GoPro
Lily Li, partner at Morrison Foerster, shares how her litigation team helped secure victory at the ITC in a patent infringement case
Sanjana Mishra, March 23 2026
Trademarks
wto.jpeg
This week on MIP: WTO to vet China’s royalty-setting practices | OpenAI, Anthropic sued again
Top talking points also included news of an appellate ruling concerning ‘Pisco’ and Indian drugmakers gearing up to launch generic versions of Ozempic as Novo Nordisk’s patent expires
Sukanya Sarkar, March 20 2026
Gift this article